The Centers for Disease Control and Prevention, more ordinarily known as CDC, is a United States federal agency operating in the Department of Health and Human Services that’s primarily answerable for protecting public health and safety by way of providing essential health-related information and forming cooperations with state health department and several other organisations.
The programs and government grants that are launched by the CDC are in accordance with their agency mission, which is to “Collaborate to form the expertise, information, and tools that people and communities need to guard their health through health promotion, controlling of disease, injury and disability, and readiness for new health threats.”
In keeping with this mission, the Centers for Disease Control and Prevention has started to collaborate with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, whereby it seeks to obtain a more intensive understanding of vaccine safety.
The discovery of vaccines is thought of as a great medical discovery as it has contributed to the successful eradication of naturally occurring smallpox, and a substantial reduction of certain illness conditions that are a result of measles, mumps, flu, hepatitis, diphtheria, and several other infections.
The Research to Advance Vaccine Safety Programme will boost this medical discovery by funding systematic studies that address potentially relevant vaccine safety concerns such as:
1) A human being’s immunological and physiological reactions to vaccine and vaccine parts.
2) The effect of genetic differentiations on an individual’s immune and physical responses.
3) The determination of biological markers and risk indicators that would potentially help in considering the relationship between certain diseases and approved vaccines
4) The analysis of statistical methodologies that are utilised in the process of researching vaccine safety.
5) The application of certain genomic and molecular technologies that would help augment vaccine safety.
In order to support this programme, the NIH and CDC are prepared to administer a maximum annual budget in the quantity of $275,000.
The establishments and organisations that will be judged able to take part in this program are the following:
a) Higher Education Institutions such as Public/State Controlled Establishments of Higher Education and Non-public Institutions of Higher Education
b) Hispanic-serving Institutions, Traditionally Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Establishments
c) Non-profitable affiliations other than establishments of higher education
d) For-Profit Affiliations like Small Businesses
e) State Regimes, County Governments, Town or Township States, Special District Executives, Indian/Indigenous American Tribal Governments (Federally Recognized), and Indian/Indigenous American Tribal Executives (Aside from Federally Recognised)
f) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Indigenous American Tribal Setups (apart from Federally recognised tribal presidencies), Faith-based or Community-based Organizations, and Regional Affiliations.
You must be logged in to post a comment.